What oral (PO) medication can be used to increase serum magnesium levels?

Oral Magnesium Supplementation

Magnesium oxide is the most commonly recommended oral medication to increase serum magnesium levels, typically dosed at 12-24 mmol daily (approximately 400-800 mg elemental magnesium), preferably given at night when intestinal transit is slowest to maximize absorption 1.

Primary Oral Magnesium Formulations

Magnesium Oxide (First-Line)

• Standard dosing: 4 mmol capsules (160 mg MgO), totaling 12-24 mmol daily 1
• Timing: Administer at night to optimize absorption during slower intestinal transit 1
• Mechanism: Insoluble in water but converts to magnesium chloride in stomach acid 1
• Contains highest elemental magnesium content among magnesium salts 1
• Evidence: Demonstrated efficacy in preventing coronary artery calcification progression in CKD patients (Japanese trial) 2

Alternative Formulations When Oxide Fails

Organic magnesium salts (citrate, aspartate, lactate, glycinate) have superior bioavailability compared to magnesium oxide or hydroxide 3. Consider these when:

• Magnesium glycinate: Emerging evidence shows effectiveness in refractory hypomagnesemia with combined malabsorption and renal wasting, where both IV magnesium sulfate and oral magnesium oxide failed 4. Achieved sustained correction (2.0-2.1 mg/dL) without further IV supplementation needed.

• Magnesium chloride: Proven effective in clinical trials for type 2 diabetes patients with hypomagnesemia. Dosing of 50 mL of 5% MgCl₂ solution (450 mg elemental magnesium) daily restored serum levels and improved insulin sensitivity 5, 6

• Magnesium pidolate: 2 g orally every 8 hours demonstrated efficacy in preventing cisplatin-induced hypomagnesemia, though mild GI symptoms (emesis, diarrhea) occurred in some patients 7

Clinical Algorithm for Magnesium Replacement

Step 1: Correct Underlying Causes First

Before initiating magnesium supplementation, address secondary hyperaldosteronism by correcting water and sodium depletion 1. This is the most critical first step, as volume depletion perpetuates magnesium wasting.

Step 2: Choose Formulation Based on Clinical Context

For standard hypomagnesemia:

• Start magnesium oxide 12-24 mmol daily at bedtime 1
• Divide doses throughout the day if tolerated for more continuous supplementation 3

For hypoparathyroidism:

• Recognize that inadequate intracellular magnesium causes PTH resistance (magnesium is cofactor for adenylate cyclase) 8
• Replace magnesium when serum levels are low, as intracellular deficiency is significant 8

For malabsorption or refractory cases:

• Switch to organic salts (glycinate, citrate, aspartate) with higher bioavailability 3, 4
• Consider magnesium glycinate specifically for post-bariatric surgery patients with renal wasting 4

For Bartter syndrome:

• Use organic magnesium salts preferentially due to better bioavailability 3
• Target plasma magnesium >0.6 mmol/L 3

Step 3: Dosing Strategy

• Spread supplementation throughout the day as much as tolerable, since urinary losses are continuous 3
• For infants on continuous tube feeds, add supplements directly into the feed 3
• Target serum magnesium >0.6-0.7 mmol/L (approximately 1.5-1.7 mg/dL) 3

Step 4: Adjunctive Measures

Reduce dietary factors that worsen magnesium balance:

• Limit excess lipid intake, which can impair magnesium absorption 1

Consider 1-alpha hydroxycholecalciferol if oral magnesium fails:

• Gradually increase dose from 0.25 to 9.00 mg daily every 2-4 weeks 1
• Monitor serum calcium regularly to avoid hypercalcemia 1

Monitor for drug interactions:

• Thiazide diuretics require monitoring of both magnesium and potassium 8
• Proton pump inhibitors may contribute to hypomagnesemia 9

Common Pitfalls and Caveats

Gastrointestinal Intolerance

Most magnesium salts are poorly absorbed and may worsen diarrhea or stomal output 1. This is the primary limitation of oral therapy. If diarrhea develops, consider:

• Switching to organic salts with better absorption
• Reducing dose and increasing frequency
• Transitioning to IV/subcutaneous administration (4-12 mmol magnesium sulfate added to saline) 1

Renal Impairment

Avoid magnesium supplements in patients with creatinine clearance <20 mL/min due to hypermagnesemia risk 10. Systemic magnesium regulation depends on renal excretion 10.

Serum Magnesium Limitations

Serum magnesium does not reliably reflect intracellular stores 8. Intracellular deficiency is significant even when serum levels are only mildly reduced. Consider clinical context and symptoms, not just laboratory values.

Formulation Bioavailability

Only magnesium oxide has been evaluated in randomized controlled trials for chronic idiopathic constipation 10. The bioavailability and clinical efficacy of other formulations (citrate, glycinate, lactate, malate, sulfate) for various indications remain incompletely characterized 10, though organic salts demonstrate superior absorption in physiological studies 3.

Comparison with IV Administration

While IV magnesium sulfate produces greater and more rapid elevations in serum magnesium compared to oral formulations 11, oral magnesium oxide provides consistent median increases of 0.1 mg/dL at baseline levels of 1.4-1.8 mg/dL 11. For cardiovascular patients, oral magnesium is appropriate for maintenance, while IV is preferred for acute severe deficiency.